Home / Education And Resources / Cancer Types

CANCER TYPES

The Association of Cancer Care Centers offers education and resources to help multidisciplinary cancer care teams stay informed of disease-specific advances, deploy strategies for effective integration into practice, and engage in bi-directional learning.

Breast Cancer

As the most common cancer among women, breast cancer accounts for approximately 30 percent of all new cancers in the United States.

Gastrointestinal Cancer

The five most common types of gastrointestinal cancer are colorectal, stomach (gastric), liver, esophageal, and pancreatic.

Genitourinary Cancer

Genitourinary cancer includes cancers of the urinary system in men and women, as well as the reproductive tract in men.

Gynecologic Cancer

Gynecologic cancer includes cervical, ovarian, uterine, vaginal, and vulvar.

Head & Neck Cancer

The five most common types of head and neck cancers are laryngeal and hypopharyngeal, nasal cavity and paranasal sinus, nasopharyngeal, oral and oropharyngeal, and salivary gland cancers.

Hematologic Malignancies

Hematologic malignancies (blood cancers) can be classified into three categories: leukemia, lymphoma, and myeloma.

Lung Cancer

There are two main types of lung cancer: non-small cell lung cancer, which accounts for 80-85 percent of lung cancer cases, and small cell lung cancer, which accounts for 10-15 percent of cases.

Sarcoma

Sarcoma is a term for a group of cancers that originate in the bones and in the soft tissues of the body such as cartilage, fat, muscle, nerves, and tendons.

Skin Cancer

Encompasses non-melanoma skin cancers (including basal cell and squamous cell carcinomas) and melanoma.

From the ACCCBuzz Blog

Expert Insights From a Multidisciplinary Panel: A Self-Assessment Tool for SCLC

Expert Insights From a Multidisciplinary Panel: A Self-Assessment Tool for SCLC

November 16, 2026

High variability in care delivery for small cell lung cancer (SCLC) across practice settings is a distinct challenge for care teams, with differences in the completeness of staging workups, timing of multidisciplinary referrals, and integration of palliative care being key areas that require standardized quality benchmarks. To meet this need, ACCC developed a quality care document and self-assessment tool for SCLC derived from insights from an expert-led Delphi panel.

Multidisciplinary Perspectives on ADCs in Bladder Cancer: Insights From Experts Around the US

Multidisciplinary Perspectives on ADCs in Bladder Cancer: Insights From Experts Around the US

November 13, 2026

ACCC spoke with providers from three cancer programs across the US about how their institutions have put ADCs into practice for patients with metastatic bladder cancer, focusing on multidisciplinary collaboration and data-driven adverse event management.

Education, Access, Efficiency, and Healing: Reimagining Comprehensive Breast Cancer Care

Education, Access, Efficiency, and Healing: Reimagining Comprehensive Breast Cancer Care

October 13, 2026

From challenging misconceptions about breast cancer to incorporating paramedical tattooing for survivors after reconstruction, gather valuable takeaways from Oncology Issues in observance of Breast Cancer Awareness Month.

Beyond the Algorithm: Using AI Across the Breast Cancer Care Continuum

Beyond the Algorithm: Using AI Across the Breast Cancer Care Continuum

October 9, 2026

Artificial intelligence is increasingly being used by cancer care professionals to streamline workflows, optimize screening, and identify the best treatment and survivorship plans for patients with cancer. Learn how the technology's potential is being harnessed in the breast cancer care space.

CANCER BUZZ Podcasts

The Urology-Oncology Partnership in ADCs - [Video Podcast] Ep. 63

July 15, 2026

In this episode, CANCER BUZZ speaks with Manojkumar Bupathi, MD, President of Rocky Mountain Cancer Centers, about how ADCs are reshaping the care model toward earlier, structured collaboration between urology and medical oncology.

A Team Approach to ADCs in Bladder Cancer – [Video Podcast] Ep. 62

July 8, 2026

In this episode, CANCER BUZZ speaks with Terence Friedlander, MD, and Iva Petrovchich Colón, NP, both part of the team treating bladder cancer at the University of California, San Francisco (UCSF), about how their cancer program manages the toxicity profile of ADCs in order to prioritize patient outcomes and quality of life.

Bridging Radiation and Oncology in SCLC Care - [Podcast] Ep. 233

June 19, 2026

In this episode, CANCER BUZZ speaks with Charles B. Simone, II, MD, FASTRO, FACRO, FACR, chief medical officer of the New York Proton Center and radiation oncologist at Memorial Sloan Kettering Cancer Center, about strategies to improve collaboration between radiation and medical oncology.

Data-Driven Toxicity Management for ADCs – [Video Podcast] Ep. 61

June 3, 2026

In this episode, CANCER BUZZ speaks with Cindy Y. Jiang, MD, assistant professor at MD Anderson Cancer Center, about how her institution conducted and implemented research to aid management of rashes and peripheral neuropathy associated with the ADC enfortumab vedotin combined with pembrolizumab.

CANCER BUZZ TV

Key Takeaways from a National Quality Improvement Initiative to Address Disparities in Bladder Cancer Care – [Video Podcast] Ep 54

February 26, 2025

Bladder cancer remains a prevalent disease with significant disparities in care, particularly in underserved populations. To address this, ACCC launched a national quality improvement initiative in three phases: 1. assessment and preparation, 2. action plan implementation, and 3. monitoring for continuous improvement. Dr. Samuel Washington, from the University of California, San Francisco, discussed the initiative’s early findings, highlighting site-specific approaches.

Exploring Bispecific Antibodies in Community Oncology: Overcoming Challenges and Harnessing Opportunities – [Video Podcast] Ep 52

December 5, 2024

In this episode, CANCER BUZZ speaks with Jean Louise Koff, MD, MSc, associate professor of hematology and medical oncology at Winship Cancer Institute of Emory University, to discuss the impact of bispecific antibodies on cancer treatment outcomes, and the challenges and opportunities of integrating this innovative approach into community oncology practices.

Establishing Goals of Treatment in Relapsed/Refractory Mantle Cell Lymphoma – [Video Podcast] Ep 51

October 2, 2024

In this episode, CANCER BUZZ speaks with Jeff Sharman, MD, medical director of hematology research, US Oncology, and director of research, Willamette Valley Cancer Institute, about the role of biomarker testing in guiding treatment decisions and how evidence-basedmanagement of treatment-related adverse events can serve this patient population.

Shared Decision Making in Relapsed/Refractory Mantle Cell Lymphoma – [Video Podcast] Ep 50

September 24, 2024

In this episode, CANCER BUZZ speaks with Nirav Shah, MD, MSHP, associate professor of medicine at Medical College of Wisconsin and Kirollos Hanna, PharmD, BCOP, PCOP, FACCC, assistant professor of pharmacy at Mayo Clinic and director of pharmacy at Minnesota Oncology, about shared decision making in the management of relapsed or refractory mantle cell lymphoma.

From Oncology Issues

Building Multidisciplinary Care Capacity for People Impacted by Hepatocellular Carcinoma

Building Multidisciplinary Care Capacity for People Impacted by Hepatocellular Carcinoma

Learn how multidisciplinary providers can enhance care for hepatocellular carcinoma patients by improving care capacity and coordination.


Carrie's TOUCH: Supporting Black Women with Breast Cancer

Carrie's TOUCH: Supporting Black Women with Breast Cancer

Maddelynne Parker and Tammie Denyse, M. DIV., MCL

With disparate breast cancer outcomes, lack of messages of hope, and limited available support for Black women, Rev. Tammie and her late sister were inspired to co-found Carrie’s TOUCH in 2006.

9 Steps to Hosting Your Own Skin Cancer Screening

9 Steps to Hosting Your Own Skin Cancer Screening

For detailed information about planning a skin cancer screening, download the Academy’s Plan an Event Toolkit at www.SpotSkinCancer.org.

Abstracts and Presentations

[Abstract] Perceived Barriers to Optimal Care in Head and Neck Cancer: A Mixed-Methods Study

November 14, 2024

Presented at Journal of the Advanced Practitioner in Oncology (JADPRO) Live 2024 in Grapevine, Texas.

[Abstract 6079 and Poster 394] Evaluating perceived barriers to optimal care in head and neck cancer: A mixed-methods study

June 19, 2024

This is a visual representation of an online publication from the American Society of Clinical Oncology 2024 Annual Meeting, May 31 – June 4, 2024.

[Abstract e18815] Using Real-World Data to Assess Variations in Cost and Healthcare Utilization for Patients Diagnosed with Bladder Cancer

May 26, 2022

This is a visual representation of an online publication from the American Society of Clinical Oncology 2022 Annual Meeting, June 3 - 7, 2022.